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Abstract
 
Optimum immunity against 
 
Mycobacterium tuberculosis
 
 requires both CD4
 
 
 
 and CD8
 
 
 
 T cells.
In contrast with CD4
 
 
 
 T cells, few antigens are known that elicit CD8
 
 
 
 T cells during infec-
tion. CD8
 
 
 
 T cells specific for culture filtrate protein-10 (CFP10) are found in purified protein
derivative positive donors, suggesting that CFP10 primes CD8
 
 
 
 T cells in vivo. Using T cells
from 
 
M. tuberculosis
 
–infected mice, we identified CFP10 epitopes recognized by CD8
 
 
 
 T cells
and CD4
 
 
 
 T cells. CFP10-specific T cells were detected as early as week 3 after infection and
at their peak accounted for up to 30% of CD8
 
 
 
 T cells in the lung. IFN
 
 
 
-producing CD8
 
 
 
and CD4
 
 
 
 T cells recognizing CFP10 epitopes were preferentially recruited to the lungs of 
 
M.
tuberculosis
 
–infected mice. In vivo cytolytic activity of CD8
 
 
 
 T cells specific for CFP10 and
TB10.3/10.4 proteins was detected in the spleen, pulmonary lymph nodes, and lungs of infected
mice. The cytolytic activity persisted long term and could be detected 260 d after infection.
This paper highlights the cytolytic function of antigen-specific CD8
 
 
 
 T cells elicited by 
 
M. tubercu-
losis
 
 infection and demonstrates that large numbers of CFP10-specific cytolytic CD8
 
 
 
 T cells
are recruited to the lung after 
 
M. tuberculosis
 
 infection.
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k
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Introduction
 
Cellular immunity to 
 
Mycobacterium tuberculosis
 
 plays a critical
role in controlling infection. An effective T cell response
determines whether immunity develops or whether the in-
fection develops into disease. CD4
 
 
 
 T cells are known to
be important both for the initial control of infection as well
as for preventing recrudescence in both mice and humans
(1). In addition to CD4
 
 
 
 T cells, CD8
 
 
 
 T cells also con-
tribute to protection against 
 
M. tuberculosis
 
 (2, 3). Although
CD4
 
 
 
 T cells primarily recognize antigens that enter the
endocytic pathway and are presented by MHC class II,
most CD8
 
 
 
 T cells recognize short peptides of 8–10 amino
acids derived from cytosolic proteins that are presented by
MHC class I molecules. Under certain conditions, MHC
class I can present antigens that enter the endocytic pathway,
a process known as cross-presentation (4). Both self- and
foreign proteins in the cytosol are cleaved by the proteo-
some and the resulting peptides are translocated into the
ER by the TAP1/TAP2 heterodimer. Once in the ER, the
peptides assemble with the class I MHC heavy chain and
 
 
 
2 microglobulin (
 
 
 
2m) to form a trimeric complex, which
is transported to the cell surface. Mice with disruptions in
the 
 
 
 
2m or TAP1 genes lack CD8
 
 
 
 T cells, are unable to
control 
 
M. tuberculosis
 
 replication in the lung, and die pre-
maturely compared with normal mice (5, 6). This is true
after large inoculums administered intravenously, as well as
after low-dose aerosol infection (7–10). Furthermore, mice
lacking CD8
 
 
 
 T cells succumb later during the course of
infection compared with mice deficient in MHC class II–
restricted CD4
 
 
 
 T cells (9). Although MHC class II–deficient
mice are more susceptible than mice lacking CD8
 
 
 
 T cells,
it is now understood that CD4
 
 
 
 T cells are required for the
development of CD8
 
 
 
 memory T cells (11).
After infection of macrophages, 
 
M. tuberculosis
 
 survives
and replicates in the phagosome. Just how bacterial anti-
gens traffic from the phagosome to the cytoplasm where
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they can enter the MHC class I processing pathway is a
matter of controversy; several mechanisms have been pro-
posed (12, 13). Once activated, CD8
 
 
 
 T cells produce cy-
tokines including IFN
 
 
 
 and TNF
 
 
 
, which can activate
macrophages and induce the production of nitrogen, oxy-
gen radicals, and LRG47 (2, 14, 15). In addition to pro-
ducing cytokines, CD8
 
 
 
 T cells mediate cellular cytotoxic-
ity. Lysis of 
 
M. tuberculosis
 
–infected macrophages could be
beneficial if the released bacteria are taken up by activated
macrophages that can mediate bacterial killing. In addition,
human CD8
 
 
 
 T cells express granulysin in their cytotoxic
granules that can directly kill intracellular 
 
M. tuberculosis
 
(16). Although murine and human 
 
M. tuberculosis
 
–specific
CD8
 
 
 
 cytolytic T cell lines have been established in vitro,
it has been difficult to demonstrate cytolytic activity of
freshly isolated CD8
 
 
 
 T cells against infected macrophages
(17–20). In addition, there has been disagreement in the
literature as to whether mice lacking critical mediators of
cytolysis, such as perforin, granzyme, or CD95, are more
susceptible to 
 
M. tuberculosis
 
 infection (21, 22). Therefore,
how CD8
 
 
 
 T cells contribute to host resistance against 
 
M.
tuberculosis
 
 remains to be delineated.
Secreted 
 
M. tuberculosis
 
 protein antigens have been ex-
tensively studied in part because they are targets of T cell–
mediated immunity (23). Antigens such as Ag85, early
secretory antigen target-6 (ESAT-6), culture filtrate pro-
tein-10 (CFP10), and others elicit strong CD4
 
 
 
 T cells re-
sponses in both mice and humans (24, 25). In contrast,
fewer 
 
M. tuberculosis
 
 antigen epitopes that are recognized by
CD8
 
 
 
 T cells have been identified. Lewinsohn et al.
cloned CD8
 
 
 
 T cells from a purified protein derivative
positive individual using autologous 
 
M. tuberculosis
 
–infected
DCs (26). Several of the CD8
 
 
 
 T cell clones were MHC
class I–restricted and two recognized peptide epitopes were
derived from the CFP10/Mtb11 protein (27). CFP10 is a
particularly interesting protein, as it is already known to be
a major antigen recognized by 
 
M. tuberculosis
 
–specific hu-
man T and B cells (28, 29). In addition, it induces a strong
delayed-type hypersensitivity response in infected guinea
pigs when injected intradermally (30, 31). CFP10 is en-
coded within the RD1 locus of the 
 
M. tuberculosis
 
 genome,
a region of DNA that is present in 
 
M. tuberculosis
 
 and
pathogenic 
 
Mycobacterium bovis
 
 strains, but is deleted from
all bacillus Calmette-Guerin (BCG) strains (32–36). The
 
cfp10
 
 gene is in the same operon as the 
 
esat-6
 
 gene, and the
two genes share 40% sequence homology and belong to
the ESAT-6 family of small proteins (34, 36, 37). In fact,
ESAT-6 and CFP10 are secreted as heterodimers, and
ESAT-6 can disrupt planar membranes (38, 39). As CFP10
and ESAT-6 are expressed by pathogenic 
 
Mycobacterium
 
species but not by BCG, CFP10 and ESAT-6 may be viru-
lence factors. Recent evidence suggests that specific immu-
nity to these proteins enhance host resistance against 
 
M. tu-
berculosis
 
 infection (40).
To understand how CD8
 
 
 
 T cells contribute to host
protection against 
 
M. tuberculosis
 
 infection, we sought to
identify bacterial protein epitopes recognized by 
 
M. tubercu-
losis
 
–specific CD8
 
 
 
 T cells that are elicited in vivo after re-
spiratory infection. Using overlapping peptides based on
the CFP10 protein, MHC class I– and class II–restricted
epitopes were identified that were recognized by CD8
 
 
 
and CD4
 
 
 
 T cells from infected mice. These epitopes were
used to compare the generation of the pulmonary CD4
 
 
 
and CD8
 
 
 
 T cell response to CFP10, and to determine
whether cytolytic CD8
 
 
 
 T cells are generated in vivo after
infection with 
 
M. tuberculosis
 
.
 
Materials and Methods
 
Mice. 
 
Age-matched female B10.BR-H2
 
k
 
 H2-T18
 
a
 
/SgSnJ
(B10.BR), B10.A-H2
 
a
 
 H2-T18
 
a
 
/SgSnJ (B10.A), C57BL/10J
(B10.J), C57BL/6 (B6), BALB/c, C3H/HeJ (HeJ), and C3H/
HeSnJ (SnJ) mice were purchased from The Jackson Laboratory.
Mice were housed in biosafety level three facilities under specific
pathogen-free conditions at the Animal Biohazard Containment
Suite (Dana Farber Cancer Institute) and were used in an ap-
proved protocol.
 
Aerosol Infection with Mycobacteria. 
 
Virulent 
 
M. tuberculosis
 
 (Erd-
man strain) were prepared as described previously (41). Mice were
 
Table I.
 
Amino Acid Sequence of the 22 Overlapping Peptides
 
NH
 
2
 
-MAEMKTDAAT
 
LAQEAGNFERISGDL
 
KTQIDQ-
 
VESTAGSL
 
QGQWRGAAGTAAQAAVVRFQEAANKQK-
QELDEISTNIRQAGVQYSRADEEQQQALSSQMGF-COOH
 
a
 
p1
 
b
 
aa 1–15
 
c
 
MAEMKTDAATLAQEA (15)
 
d
 
p2 aa 6–20 TDAATLAQEAGNFER (15)
p3 aa 11–25 LAQEAGNFERISGDL (15)
p4 aa 16–30 GNFERISGDLKTQI (14)
p5 aa 20–32 RISGDLKTQIDQV (13)
p6 aa 23–36 GDLKTQIDQVESTA (14)
p7 aa 27–39 TQIDQVESTAGSL (13)
p8 aa 30–44 DQVESTAGSLQGQWR (15)
p9 aa 35–47 TAGSLQGQWRGAA (13)
p10 aa 38–51 SLQGQWRGAAGTAA (14)
p11 aa 41–55 GQWRGAAGTAAQAAV (15)
p12 aa 46–58 AAGTAAQAAVVRF (13)
p13 aa 49–62 TAAQAAVVRFQEAA (14)
p14 aa 53–66 AAVVRFQEAANKQK (14)
p15 aa 57–69 RFQEAANKQKQEL (13)
p16 aa 60–72 EAANKQKQELDEI (13)
p17 aa 63–77 NKQKQELDEISTNIR (15)
p18 aa 68–81 ELDEISTNIRQAGV (14)
p19 aa 72–86 ISTNIRQAGVQYSRA (15)
p20 aa 77–93 RQAGVQYSRADEEQQQA (17)
p21 aa 84–98 SRADEEQQQALSSQM (15)
p22 aa 89–100 EQQQALSSQMGF (12)
 
a
 
Amino acid sequence of the CFP10 protein from 
 
M. tuberculosis
 
 (refer-
ence 37).
 
b
 
Peptide name used in the text and in Fig. 1.
 
c
 
Location of peptide within the CFP10 protein.
 
d
 
Amino acid sequence of peptide and, in parentheses, length. 
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infected via the aerosol route using a nose-only exposure unit
(Intox Products; reference 42).
 
Peptides. 
 
Overlapping peptides spanning the CFP10 protein
sequence of 
 
M. tuberculosis
 
 were designed using the PeptGen
web-based program (http://www.hiv.lanl.gov). The length of
each peptide was 15 amino acids with a 10–amino acid overlap,
but the length was adjusted to avoid C-term amino acids GPED
QNTSC or the NH
 
2
 
-terminal amino acid Q. The 22 resulting
peptides were commercially synthesized (BioSource International;
Table I). The identity of each peptide was confirmed by mass
spectrophotometry. The peptides were dissolved in DMSO and
stored at 
 
 
 
20
 
 
 
C until used. Peptides used for immunological as-
says were unpurified. The purity of peptides used for tetramer
production was 
 
 
 
95%.
 
In Vitro Restimulation Assays. 
 
Single cell suspensions were
prepared from spleens and pulmonary LNs (PLNs) of infected
mice. The RBCs were lysed using lysis buffer (0.15 M NH
 
4
 
Cl, 1
mM KHCO
 
3
 
, 0.1 mM Na EDTA, pH 7.3). After washing, the
cells were resuspended in complete medium (RPMI 1640, 10%
FCS, 2% Hepes, 1% 
 
l
 
-glutamine, 1% penicillin-streptomycin,
0.1% 
 
 
 
-mercaptoethanol). Lung mononuclear cells were obtained
by digesting tissue with collagenase type IV (Sigma-Aldrich) fol-
lowed by filtration through a 60-mesh metal strainer and 70-
 
 M
nylon strainer (Fisher Scientific). RBC lysis was performed as de-
scribed before. CD8  T cells were purified from infected spleens,
PLNs, or lungs using immunomagnetic beads and MACS LS 
columns (Miltenyi Biotec) in two steps. First, using the Pan–T cell
isolation kit, total T cells were purified by negative selection, fol-
lowed by a second step using immunomagnetic beads to positively
purify either CD4  or CD8  T cells. In all experiments, the pu-
rity of the cells was 90–95% as determined by flow cytometry.
The purified CD4  or CD8  T cells were stimulated with syn-
thetic peptides and irradiated naive splenocytes as APCs for 48 h
in vitro (42). Recombinant IL-2 (Chiron Corp.) and IL-15 (R&D
Systems) were added to the assay medium at 100 U/ml and 20
ng/ml, respectively, to promote CD8  T cell growth. Culture su-
pernatants were assayed for IFN  by an ELISA, using antibody
pairs and cytokines obtained from BD Biosciences.
ELISPOT Assay for IFN .  The ELISPOT method was used
to detect IFN  secretion by individual CD8  T cells from in-
fected mice after stimulation with peptides in vitro. In brief, using
the ELISPOT kit and protocol (BD Biosciences): ELISPOT plates
were coated with capture IFN  antibody overnight at 4 C. The
capture antibody was discarded, and the plates were washed and
blocked with complete media for 2 h at room temperature. Puri-
fied CD8  T cells were added along with CFP10 peptides and ir-
radiated naive splenocytes as APCs and cultured for 36–40 h at
37 C. The cells were discarded, and plates were washed with de-
ionized water and PBS/Tween 20. Secondary biotinylated anti-
body was added for 2 h and incubated at room temperature fol-
lowed by washing with PBS/Tween 20. Streptavidin–alkaline
phosphatase was added to the plates for 1 h followed by washing
and development of a color reaction using the substrate AEC sub-
strate reagent kit (BD Biosciences). The reaction was stopped
when the spots developed by running the plate under water. The
spots were enumerated using a dissecting microscope.
In Vivo Cytotoxicity Assay. Splenocytes from naive C3H or
BALB/c mice were prepared as described before. Half of the
splenocytes were labeled with 0.5  M (CFSElow) and the other
half with 5  M (CFSEhigh) CFSE (Molecular Probes) in PBS for
10 min at room temperature, followed by extensive washing. For
experiments using C3H mice, the CFSElow population was pulsed
with 10  M of the H-2Kk–specific peptide, VESTAGSL. For ex-
periments with BALB/c mice, the CFSElow cells were pulsed
with 10  M of the H-2Kd–specific peptide, GYAGTLQSL. In
both cases, the cells were cultured with the peptide in complete
medium for 1 h at 37 C, washed, and resuspended in complete
medium. Both the CFSE populations were mixed at a 1:1 con-
centration and injected intravenously into naive or infected C3H
or BALB/c mice at a concentration of 107 cells/mouse. After
18 h, the spleens, PLNs, and lungs were harvested, and single cell
suspensions were made as described before. Each experimental
group consisted of three to five mice, and each mouse was ana-
lyzed individually. The CFSElow or CFSEhigh populations of lym-
phocytes were detected in all the organs via flow cytometry using
the FACSort (Becton Dickinson) and analyzed using FlowJo soft-
ware (Treestar Inc.). Percent of peptide-specific lysis was deter-
mined by the formula: % lysis   100   100   [(%CFSElow/
%CFSEhigh infected)/(%CFSElow/%CFSEhigh uninfected)].
Flow Cytometry and Tetramer Staining.  Purified lymphocytes
from the spleens, PLNs, and lungs were resuspended at a concen-
tration of 106 cells/sample in FACS buffer and stained with an
isotype-matched control IgG or antibodies specific for mouse
CD4, CD8, CD22, conjugated to FITC, PE, or streptavidin-Cy
(BD Biosciences). Tetramers were produced using VESTAGSL-
loaded H-2Kk or GYAGTLQSL-loaded H-2Kd, both complexed
with PE (National Institute of Allergy and Infectious Diseases tet-
ramer facility). Cells were stained with the tetramers at an opti-
mum concentration (1:200) for 20 min on ice, washed, and fixed
in 1% paraformaldehyde overnight. Cells were analyzed using a
FACSort and FlowJo software was used to analyze the data.
Peptide-binding Assay. RMA-S peptide-binding assay was per-
formed essentially as described previously (43). In brief, RMA-S/
Kk cells (provided by P. Cresswell, Yale University, New Haven,
CT) were incubated overnight at 23 C in complete media. Cells
were pulsed for 1–2 h with peptide CFP1032-39 at 23 C, washed,
and incubated at 37 C without peptide for 4 h. Cells were
washed, stained for H-2Kk expression using biotinylated H2-Kk
monoclonal antibody and streptapavidin-PE-Cy5 (BD Biosciences),
and analyzed using a FACSort and FlowJo software.
Statistics.  One-way analysis of variance (ANOVA) with Dun-
nett’s posttest and two-way ANOVA with Bonferroni’s posttest
were performed using Prism version 4.02 for Windows (Graph-
Pad Software).
Results
CFP10-specific MHC Class I–restricted CD8  T Cells Are
Elicited after Respiratory Infection with M. tuberculosis. Over-
lapping peptides spanning the CFP10 protein (Table I)
were screened to identify antigen epitopes recognized by
CD8  T cells that are elicited during M. tuberculosis infec-
tion. B6 (H-2b), C3H (H-2k), and BALB/c (H-2d) mice
were infected with virulent M. tuberculosis via the aerosol
route and their spleens were harvested 4 wk after infection
at the peak of the immune response (41). Purified CD4  or
CD8  T cells were cultured with the individual peptides
and naive irradiated syngeneic splenocytes, and after 48 h,
the culture supernatants were assayed for IFN  as a mea-
sure of T cell activation. Peptide 3 (LAQEAGNFERIS-
GDL; herein referred to as CFP1011-25) was recognized by
CD4  T cells and the overlapping peptides 7 (amino
acid  [aa] 27–39: TQIDQVESTAGSL) and 8 (aa 30–44:
DQVESTAGSLQGQWR) were recognized by CD8  TCFP10-specific CTL in the Lungs after Tuberculosis 1482
cells from C3H mice, but not B6 or BALB/c mice (Fig. 1).
Peptides 7 and 8 were only recognized by purified CD8 
T cells, but not CD4  T cells from infected C3H mice
(Fig. 2 A). To identify the minimal antigenic epitope, three
overlapping peptides were synthesized, IDQVESTA (aa
29–36), DQVESTAGSL (aa 30–39), and VESTAGSL (aa
32–39), that spanned the sequence common to peptides 7
and 8. The 8mer VESTAGSL was identified as the minimal
antigenic epitope recognized by CD8  T cells from in-
fected C3H mice (Fig. 2, A and B). To identify which
MHC class I molecule presents VESTAGSL, naive con-
genic B10 mice were used as APCs. Purified CD8  T cells
from infected C3H (H-2k) mice were tested for their ability
to recognize the 8mer VESTAGSL presented by either
B10.J (H-2b), B10.A (H-2a), or B10.BR (H-2Kk) irradiated
splenocytes. CD8  T cells recognized VESTAGSL pre-
sented by B10.BR splenocytes (KkDkLk) and B10.A
(KkDdLd) splenocytes, indicating that H-2Kk is the restrict-
ing element (Fig. 2 C). The VESTAGSL peptide contains
the H-2Kk binding motif (http://syfpeithi.bmi-heidelberg.
com), and the VESTAGSL peptide stabilized the expres-
sion of H-2Kk by RMA-S transfectants, verifying that it
binds to H-2Kk (reference 44 and unpublished data). Not
only did the CFP10 epitope prime CD8  T cells in vivo
but also a CD8  T cell line specific for the VESTAGSL
peptide recognized peritoneal macrophages infected in
vitro with M. tuberculosis (unpublished data). These data in-
dicate that after infection of C3H mice with M. tuberculo-
sis, H-2Kk–restricted CD8  T cells are primed that recog-
nize the CFP10 epitope VESTAGSL (herein referred to as
CFP1032-39).
Priming of CFP10-specific CD4  and CD8  T Cells Occurs
Rapidly after Infection with M. tuberculosis. To determine
the frequency of CFP1032-39-specific CD8  T cells, an
IFN  ELISPOT assay was developed. Purified splenic
CD8  T cells from either infected or uninfected C3H/HeJ
mice were cultured with the H-2Kk–restricted CFP1032-39
peptide and irradiated naive splenocytes as APCs. To dem-
onstrate the specificity of the ELISPOT assay, an H-2Kd–
Figure 1. Identification of a new MHC class I–restricted M. tuberculosis
epitope recognized by CD8  T cells. Purified CD4  and CD8  T cells
from splenocytes of week 4–infected C57BL/6, BALB/c, and C3H/HeSnJ
mice were cultured with CFP10 peptides at a concentration of 10  M and
syngeneic naive irradiated splenocytes as APCs. The amount of IFN  re-
leased into the supernatants was measured by ELISA after 48 h. The data
represent one out of three independent experiments with similar results
Figure 2. Identification of the minimal epitope and restricting element
recognized by CD8  T cells. (A) Definition of the minimal epitope rec-
ognized by CFP10-specific CD8  T cells. Purified CD4  and CD8 
splenic T cells obtained from C3H/HeSnJ mice 4 wk after infection were
cultured with p7 or p8 from the CFP10 peptide library, or the overlapping
peptides VESTAGSL, DQVESTAGSL, and IDQVESTA (all at 10  M).
IFN  in the culture supernatants was measured after 48 h by ELISA. The
CD8  T cell responses to VESTAGSL, DQVESTAGSL, p7, and p8 are
all statistically significant (P   0.05) compared with media alone when
analyzed by one-way ANOVA. (B) Dose–response of CFP10-specific
CD8  T cells to specific peptides. Splenic CD8  T cell responses to over-
lapping peptides VESTAGSL, DQVESTAGSL, and IDQVESTA. The
responses to VESTAGSL and DQVESTAGSL were similar to each other
and both are significantly different from the response to IDQVESTA (P  
0.01, by two-way ANOVA). (C) Recognition of CFP10 by CD8  T
cells was restricted by H-2Kk. IFN  production was used to indicate
splenic CD8  T cell recognition of the VESTAGSL peptide when pre-
sented by irradiated splenocytes obtained from B10.BR, B10.A, or B10.J
mice. ***, P   0.001 by two-way ANOVA with Bonferroni’s posttest.
Results shown are representative of at least three independent experi-
ments. Error bars represent SD.Kamath et al. 1483
restricted epitope, GYAGTLQSL, from the TB10.3 and
TB10.4 proteins of M. tuberculosis was used (herein referred
to as TB10.3/420-28; reference 45). CD8  T cells from in-
fected C3H mice recognized the CFP1032-39 peptide, but not
the TB10.3/420-28 peptide. Conversely, CD8  T cells from
infected BALB/c mice recognized the H-2Kd–restricted
epitope, but not the H-2Kk–restricted CFP1032-39 peptide.
CD8  T cells from uninfected BALB/c mice and C3H/
HeJ mice did not recognize either peptide as expected (Fig.
3 A). These results demonstrate the specificity of the
ELISPOT in detecting CFP1032-39-specific H-2Kk–restricted
CD8  T cells, and independently confirm that H-2Kd–
restricted CD8  T cells specific for the TB10.3/10.4 pro-
tein are elicited by M. tuberculosis infection.
To compare the priming of CD4  and CD8  T cells
specific for CFP10 protein, we used the MHC class II– and
class I–restricted CFP10 epitopes and measured the T cell
response to CFP10 using the IFN  ELISPOT assay.
The frequency of CFP1011-25-specific CD4  T cells and
CFP1032-39-specific CD8  T cells in the PLNs, lung, and
spleen was compared after infection of C3H mice with
aerosolized M. tuberculosis. CD8  or CD8  (e.g., CD4 ) T
cells were purified from the infected organs 2–5 wk after
infection and cultured with irradiated splenocytes from un-
infected C3H mice with either the CFP1032-39 or CFP1011-25
peptides, respectively.
2 wk after infection, a small number of peptide-specific
IFN  spots could be detected in the PLNs, spleen, and
lung. Although a significant increase in the frequency of
CFP10-specific CD4  and CD8  T cells in the PLNs was
observed by week 3, it never reached a frequency  0.05–
0.075%. This indicates that antigen-specific T cells fail to
accumulate in the PLNs, despite the presence of bacteria at
this site (42). In contrast, a rapid increase in the frequency
of CFP10-specific T cells occurred between 2 and 3 wk af-
ter infection in the lung and spleen (Fig. 3 B). The number
of CFP10-specific CD4  and CD8  T cells steadily in-
creased in the spleen and reached a peak between weeks 4
and 5. In the lungs of infected mice, there was a noticeable
enrichment of CFP10-specific T cells. The frequency of
CFP1011-25-specific CD4  T cells in the lung increased
 180-fold between week 2 (25 spots/105 CD4  T cells)
and week 5 (4538 spots/105 CD4  T cells) (Fig. 3 B). A
high frequency of CFP1032-39-specific CD8  T cells was
also detected in the lungs, representing  1% of the CD8 
T cells (Fig. 3 C). Therefore, priming of the CFP10-spe-
cific CD4  and CD8  T cells occurs with similar kinetics
and, once elicited, undergo expansion and accumulate par-
ticularly in the spleen and lung.
Antigen-specific CD8  T Cells Are Enriched in the Lung after
Infection with M. tuberculosis. The IFN  ELISPOT re-
vealed an unexpectedly high frequency of CFP10-specific
CD8  and CD4  T cells in the lungs of C3H mice. To
corroborate the ELISPOT assay results, flow cytometry
was performed using H-2Kk tetramers loaded with the
CFP1032-39 peptide and H-2Kd tetramers made with the
TB10.3/420-28 peptide. These tetrameric complexes were
used to stain CD8  T cells from uninfected or M. tuberculo-
sis–infected C3H/HeJ and BALB/c mice. The H-2Kk tet-
ramer specifically stained splenic CD8  T cells from
infected, but not uninfected, C3H/HeJ mice (Fig. 4).
Conversely, the H-2Kd tetramers detected TB10.3/420-28-
specific CD8  T cells in the spleens of infected, but not
uninfected, BALB/c mice. Neither tetramer stained CD8 
T cells from uninfected C3H/HeJ or BALB/c mice. These
Figure 3. Enumeration of the peptide-specific CD4  and CD8  T
cells after M. tuberculosis infection using the ELISPOT assay. (A) Epitope
specificity and H-2 restriction of the ELISPOT assay. Purified splenic
CD8  T cells from uninfected or infected C3H/HeJ or BALB/c mice
were cultured with syngeneic APCs in the presence of the H-2Kk–restricted
CFP1032-39 or H-2Kd–restricted TB10.3/420-28 peptides and an IFN 
ELISPOT assay was performed. ***, P   0.001 by two-way ANOVA
with Bonferroni’s posttest. (B and C) The kinetics of the CFP10-specific
T cell response. Purified CD4  T cells (B) or CD8  T cells (C) from in-
fected C3H/HeJ mice were cultured with the I-Ak–restricted CFP1011-25
peptide or the H-2Kk–restricted CFP1032-39 peptide in the presence of
syngeneic irradiated splenocytes as APCs. The T cells were purified from
pooled organs of six infected mice at each time point. Controls without
peptide produced a minimal background level of IFN   spots and this
was subtracted from the number of spots in the presence of the peptide.
The data are representative of two independent experiments and shown
as the number of spot-forming cells/100,000 CD4  or CD8  T cells. Error
bars represent SD.CFP10-specific CTL in the Lungs after Tuberculosis 1484
data confirm with reasonable certainty that the H-2Kk and
H-2Kd tetramers specifically stain CD8  T cells specific for
their respective MHC–peptide complexes.
Very few tetramer-specific CD8  T cells were detected
in the PLNs at all times tested (unpublished data). The
finding that CFP10-specific CD4  and CD8  T cells do
not accumulate in the draining LNs suggests that, although
T cell priming may occur in the LNs (42), once activated,
antigen-specific T cells rapidly traffic to other sites of dis-
ease. In contrast, a surprisingly high frequency of H-2Kk
tetramer  CD8  T cells was detected in the lungs of M. tu-
berculosis–infected C3H mice. At week 2, 0.014% of CD8 
T cells stained with the H-2Kk tetramer, which increased
to 2.75% at week 3 and to 8.12% by week 5, representing a
512-fold increase between weeks 2–5 (Fig. 5 A). In more
chronically infected mice, up to 30% of CD8  T cells were
CFP1032-39-specific based on staining with the tetramer.
CD8  T cells obtained from bronchoalveolar lavage fluid
of infected mice contained a comparable proportion of
CFP1032-39-specific H-2Kk–restricted CD8  T cells as did
the lung (unpublished data). In the spleens, a similar in-
crease in tetramer  CD8  T cells was observed. Although
the correlation was very good, the ELISPOT tended to un-
derestimate the frequency of antigen-specific T cells deter-
mined using the tetramers. This discrepancy could be the
result of a technical problem such as nonspecific tetramer
staining, although numerous controls did not identify this
as a significant source of error (Fig. 4), or that the culture
conditions for the ELISPOT do not activate 100% of the
antigen-specific CD8  T cells. Alternately, this discrepancy
may have a biological explanation. Although the tetramer
detects all of the CFP1032-39-specific H-2Kk–restricted
CD8  T cells, the ELISPOT only detects the subset that
secretes IFN . A similar discrepancy between tetramer
staining and ELISPOT has also been observed in viral
models and has been suggested to be a consequence of T
cell exhaustion or T cell anergy (46, 47). Finally, CFP10-
specific CD8  T cells were also detected in resistant
B10.BR mice, which had a greater percentage of tetramer 
CD8  T cells in their spleens and lungs after infection with
M. tuberculosis than did C3H mice (Fig. 5 B). Regardless,
combining the tetramer and ELISPOT data, one observes a
specific enrichment of CFP10-specific CD4  and CD8  T
cells in the lung compared with the spleen during the first
few weeks of infection.
Peptide-specific Cytotoxic CD8  T Cells Are Recruited to the
Lung after M. tuberculosis Infection. An important question
concerning the function of M. tuberculosis–specific CD8  T
cells is whether they mediate any unique functions in host
defense against infection. One possibility is that these
CD8  T cells function as cytolytic T cells in vivo. Bulk
CD8  T cells stimulated in vitro acquire the capacity to
lyse infected macrophages in vitro; however, it is unclear
whether they have this function in vivo (48, 49). To ad-
dress whether CD8  T cells elicited during infection are
cytolytic in vivo, we adoptively transferred peptide-pulsed
or unpulsed, CFSE-labeled splenocytes into uninfected or
infected mice to demonstrate in vivo cytotoxicity (50).
This approach has been used to demonstrate viral CTL ac-
tivity in vivo and allowed us to determine whether the
CFP1032-39 peptide sensitized splenocytes to lysis by CTL
elicited after M. tuberculosis infection (51–54). Killing of
peptide-pulsed splenocytes by CD8  T cells in vivo was
detected as early as week 3 after infection in the spleen and
lung and 1 wk later in the PLNs when compared with the
lungs and spleens of naive mice (Fig. 6, A and B). These
data correlate with the results of the ELISPOT assay de-
picted in Fig. 3, in which very few antigen-specific CD8 
T cells were detected at week 2, but increased dramatically
at weeks 3 and 4. Strikingly, the ability of the T cells to re-
main cytotoxic was stable over time up to 6 wk after infec-
tion, at which time the majority of mice succumbed to in-
fection. To determine how long the in vivo CTL activity
persisted, we turned to BALB/c mice, which survive for
up to 1 yr after infection. CD8  T cells from Mycobacte-
rium-infected BALB/c mice killed TB10.3/420-28-pulsed
P815 targets after in vitro stimulation (45). After adoptive
transfer of CFSE-labeled unpulsed and TB10.3/420-28-
pulsed splenocytes into uninfected and infected BALB/c
mice, we observed killing of TB10.3/420-28-pulsed spleno-
cytes in the lungs of infected BALB/c mice (Fig. 6 C).
Upon M. tuberculosis infection, in vivo cytolytic activity was
Figure 4. H-2Kk and H-2Kd peptide tetramer staining of CD8  T cells
in M. tuberculosis–infected C3H/HeJ or BALB/c mice. Purified CD8  T
cells from splenocytes of naive or 4 wk–infected C3H/HeJ or BALB/c
mice were stained with the CFP1032-39/H-2Kk or TB10.3/420-28/H-2Kd
tetramers. A significant population of H-2Kk and the H-2Kd tetramer 
CD8  T cells was found only in cells obtained from the infected C3H/
HeJ and BALB/c mice, respectively. All of the CD8  T cells are within
the rectangular gate and all of the tetramer  cells are within the oval gate.
The number represents the percentage of CD8  T cells that are tetramer .Kamath et al. 1485
detected as early as 4 wk after infection and persisted at
least to 37 wk. This is the first paper showing in vivo cy-
tolytic activity mediated by pulmonary CD8  T cells spe-
cific for the CFP10 and TB10.3/10.4 proteins.
Discussion
Based on a variety of data, including the increased suscep-
tibility of  2m, TAP1, KdDb, and CD8 knockout mice to
infection, it has become clear that CD8  T cells play a criti-
cal role in mediating protective immunity to M. tuberculosis
(1, 5–10). CD8  T cells can recognize infected cells, pro-
duce cytokines such as TNF  and IFN , lyse infected cells,
and kill M. tuberculosis. Although CD8  T cells specific for
mycobacterial proteins can be elicited by vaccination using
antigen 85A (aa 144–152), 38kD (aa 225–234), and MPT4
(aa 190–198), MHC class I–presented bacterial epitopes that
prime CD8  T cells during infection remain elusive (55–
57). Some progress has been made in identifying the anti-
gens recognized by human CD8  T cells, and several of
these are proteins secreted by M. tuberculosis. In fact, it has
been proposed that antigens secreted early during the course
of M. tuberculosis infection account for the ability of live, but
not heat-killed, M. tuberculosis to confer protection in animal
models (58). One of these secreted proteins is the 10-kD
protein (CFP10), which is a major antigen recognized by
human T and B cells after infection (27–29, 59). We rea-
Figure 5. Detection of
tetramer  CD8  T cells in the
spleens and lungs of C3H/HeJ and
B10.BR mice after M. tuberculosis
infection. (A) Purified CD8  T
cells from splenocytes of infected
C3H/HeJ mice were stained at
various times after infection.
Tetramer  CD8  T cells could be
detected in the spleens and lungs
of infected C3H/HeJ mice as early
as 3 wk after infection. The per-
cent of tetramer  CD8  T cells is
shown in all panels. (B) CFP10-
specific CD8  T cells in C3H/
HeJ and B10.BR mice after infec-
tion. The percentage of tetramer 
CD8  T cells found in the spleens
and lungs of resistant B10.BR
mice and susceptible C3H/HeJ
mice were compared 4 wk after
infection with M. tuberculosis. All
of the CD8  T cells are within the
rectangular gate and all of the
tetramer  cells are within the oval
gate. The number represents the
percentage of CD8  T cells that
are tetramer .
Figure 6. Generation of peptide-specific cytotoxic CD8  T cells after
M. tuberculosis infection. (A) In vivo cytolytic activity of CFP1032-39-specific
CD8  T cells. A 1:1 mixture of CFSEhigh and CFP1032-39-pulsed CFSElow
splenocytes were injected i.v. into C3H/HeJ that were uninfected or in-
fected 3–6 wk previously with M. tuberculosis. The spleens of the recipient
mice were removed after 18 h and analyzed by flow cytometry. A histo-
gram gated on CFSE  events is shown for a representative mouse from
each group. The number in each plot represents the percent killing of the
CFP1032-39-pulsed CFSElow splenocytes, which was calculated as described in
Materials and Methods. (B) The relative killing of the peptide-pulsed targets
in the lungs, PLNs, and spleens of infected mice compared with unin-
fected mice was calculated as described in Materials and Methods. Each
point represents the mean   SD of five mice per group. The experiment
was repeated twice with similar results. (C) Uninfected (U) or infected
BALB/c mice were injected as described before with TB10.3/420-28-
pulsed and unpulsed splenocytes. The percent killing in the lungs of indi-
vidual mice from 28 to 260 after infection is shown. Each symbol repre-
sents an individual mouse.CFP10-specific CTL in the Lungs after Tuberculosis 1486
soned that CFP10 would be recognized by murine CD8  T
cells after infection in vivo, and that the immune response
to CFP10 may be an important component of host immu-
nity to M. tuberculosis. Therefore, we screened overlapping
peptides spanning the sequence of the CFP10 protein to de-
termine whether murine CD8  T cells specific for CFP10
are elicited by M. tuberculosis infection.
A minimal epitope (VESTAGSL; CFP1032-39) was iden-
tified that is presented by H-2Kk to CD8  T cells primed
during infection. From the same peptide library, a second
epitope was identified (LAQEAGNFERISGDL; CFP1011-25)
that is recognized by CD4  T cells. Both the CD4  and
CD8  T cell responses to CFP10 evolved similarly in the
spleen, lung, and draining LNs of infected C3H/HeJ mice.
The CFP10-specific response was detected as early as 2 wk
and peaked at weeks 4 and 5. Using CFP1032-39-loaded
H-2Kk tetramers, antigen-specific CD8  T cells could be
detected ex vivo in the lungs, spleens, and PLNs of infected
mice, although antigen-specific CD8  T cells were selec-
tively enriched in the lungs of infected mice. We found up
to 30% of pulmonary CD8  T cells in infected mice
stained with the CFP1032-39–H-2Kk tetramers. This high
frequency of antigen-specific T cells is similar to what is
seen in Listeria monocytogenes infection (60). Pope et al.
showed that the magnitude of the CD8  T cell response
measured by MHC class I tetramers is increased in the non-
lymphoid organs when compared with the secondary lym-
phoid organs in L. monocytogenes infection (61). In our cur-
rent analysis, we too detected an increase in tetramer 
CD8  T cells in the lungs when compared with the spleen
and PLNs. After short-term stimulation with infected DCs,
lung CD8  T cells produce IFN , although CD4  T cells
appear to be the major source of this cytokine (14). We
have extended these results to demonstrate that antigen-
specific CD8  T cells that produce IFN  are recruited to
the lung early after infection. Furthermore, our finding that
CFP1032-39-specific CD8  T cells are greatly enriched in
the lung compared with other sites of infection such as the
spleen or LNs provides the first evidence that antigen-spe-
cific CD8  T cells specifically accumulate in the lung, as
opposed to the nonspecific recruitment of CD8  T cells
because of the production of chemokines, proinflammatory
cytokines, and the up-regulation of cell adhesion molecules
in the lung.
The function of CD8  T cells in tuberculosis is not en-
tirely clear, and there is conflicting data whether mice with
targeted deletion of cytotoxic granule proteins are more
susceptible to tuberculosis. Furthermore, significant cyto-
lytic activity of CD8  T cells against infected macrophages
has been difficult to demonstrate ex vivo and usually
requires stimulation of the T cells in vitro before lysis of
target cells can be observed. Having identified an MHC
class I–restricted epitope, we were able to demonstrate that
CFP10-specific CD8  T cells were cytolytic in vivo.
Other M. tuberculosis antigens have recently been reported
to be recognized by MHC class I–restricted CD8  T cells.
The epitope GYAGTLQSL that is derived from the
TB10.3 and TB10.4 proteins are recognized by H-2Kd–
restricted CD8  T cells from M. tuberculosis and BCG-
infected mice (45). By using H-2Kd tetramers and ELISPOT
assay, we have extended these results to show that a signifi-
cant number of TB10.3/420-28-specific CD8  T cells are
present in the lungs of infected mice. Furthermore, the
CD8  T cells that recognize this peptide are cytolytic in
vivo and their cytolytic activity could be detected even as
late as 260 d after infection. An epitope from the phos-
phate-binding protein PstS-3 also contains an epitope rec-
ognized by CD8  T cells from infected C57BL/6 mice
(62). In contrast with CFP10 and TB10.3/10.4, PstS3-spe-
cific CD8  T cells in the peripheral blood could not be de-
tected using peptide-loaded Db-tetramers, probably be-
cause their frequency,  0.02% in the spleen, is too low
(62). Nevertheless, cytolytic T cells specific for this peptide
appear to exist in the spleen, although the induction of in
vivo CTL activity only appeared 8–10 wk after infection.
These data suggest that the cytolytic activity appears to be
related to the frequency of antigen-specific CD8  T cells.
CD8  T cells can kill target cells by several mechanisms,
including the release of cytotoxic granules containing per-
forin and granzymes, CD95/CD95L-dependent killing,
and the production of TNF  that induces apoptosis in
some sensitive targets. Although disagreement exists about
the requirement for cytotoxic molecules, perforin and
CD95 appear to be needed under some conditions for op-
timum host resistance in murine models of tuberculosis (7,
21, 22). One reason for the discrepancies in published stud-
ies is that the requirement for CD8  T cells may be more
critical late during the course of infection. Studies that fo-
cused on early time points generally did not observe signif-
icant differences, whereas survival studies more typically
reported a requirement for cytotoxic molecules. This possi-
bility is supported by the finding that CD8  T cell deple-
tion leads to greater disease exacerbation when performed
late during the course of aerosol infection (63). Interest-
ingly, mice lacking CD8  T cells (i.e.,  2m, TAP1, and
CD8 knockout mice) die more rapidly than mice lacking
perforin, suggesting there may be some redundancy for cy-
totoxic pathways, as has been observed in certain viral sys-
tems (64, 65). Alternately, CD8  T cells may mediate
other functions, and at least one paper has emphasized that
IFN  production by CD8  T cells can be protective (66).
After in vitro stimulation of pulmonary CD8  T cells with
M. tuberculosis–infected DCs, CD8  T cells acquire the
ability to lyse infected macrophages in vitro, and the lysis is
dependent on granule exocytosis (67). The establishment of
a robust in vivo CTL assay will allow the dissection of the
molecular pathways used by CTLs generated in M. tubercu-
losis–infected mice.
The continuing HIV/AIDS epidemic and the spread of
multidrug-resistant  M. tuberculosis has contributed to the
perpetuation of the global epidemic of tuberculosis. Al-
though M. bovis BCG is used universally as a vaccine, its ef-
ficacy in preventing pulmonary tuberculosis in adults is
controversial (68). Antigen-specific CD8  T cells are con-
sidered to be important for vaccine-induced immunity, and
several of the vaccine strategies currently being evaluatedKamath et al. 1487
are ones that potentially elicit CD8  T cells. However, the
paucity of defined human and murine epitopes recognized
by MHC class I–restricted CD8  T cells has impaired their
immunological evaluation. Our paper has defined epitopes
of the CFP10 protein that are presented by MHC class I
and class II. Although we cannot say whether these are im-
munodominant epitopes, it clearly elicits a vigorous CTL
response that is recruited to the lungs, and accounts for up
to 30% of the pulmonary CD8  T cells. These epitopes
will make possible further insight into how CD8  T cells
mediate host resistance to tuberculosis and allow compari-
son of different vaccination strategies that elicit CD8  T
cell responses.
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